Skip to main content

Table 1 Characteristics of hospitalized children with PIV-1, PIV-2, PIV-3, and PIV-4 including co-detections with other pathogens

From: Clinical features of parainfluenza infections among young children hospitalized for acute respiratory illness in Amman, Jordan

 

PIV-1

(n = 34)

No. (%)

PIV-2

(n = 13)

No. (%)

PIV-3a

(n = 125)

No. (%)

PIV-4a

(n = 46)

No. (%)

p-value

Female sex

16 (47.1)

6 (46.2)

48 (38.4)

21 (45.7)

0.714

Median age, months (IQR)

9.0 (3.5–16.1)

5.4 (2.6–8.6)

3.2 (1.7–8.9)

2.6 (1.7–9.1)

0.003

Age group

  < 6 months

13 (38.2)

7 (53.9)

80 (64.0)

29 (63.0)

0.028

 6 to < 12 months

7 (20.6)

5 (38.5)

23 (18.4)

8 (17.4)

 12 to < 24 months

14 (41.2)

1 (7.7)

22 (17.6)

9 (19.6)

Received influenza vaccine

0 (0)

0 (0)

1 (1.0)

0 (0)

0.861

Breastfed, any

30 (88.2)

13 (100)

92 (73.6)

37 (80.4)

0.059

Any underlying medical conditionb

3 (8.8)

2 (15.4)

19 (15.2)

6 (13.0)

0.810

Household smoke exposure

23 (67.7)

10 (76.9)

95 (76.0)

37 (80.4)

0.620

Symptom duration prior to admission, days (IQR)

3.5 (2–5)

2 (2–4)

3 (2–5)

2 (1–5)

0.253

Antibiotics prior to admission

17 (50.0)

3 (23.1)

42 (33.6)

19 (41.3)

0.210

Antibiotics during hospitalization

33 (97.1)

9 (69.2)

115 (92.0)

44 (95.7)

0.010

Clinical presentation

 Fever/feverishc

21 (61.8)

9 (69.2)

77 (61.6)

27 (58.7)

0.923

 Coughc

30 (88.2)

10 (76.9)

90 (72.0)

36 (78.3)

0.258

 Shortness of breathc

23 (67.7)

9 (69.2)

55 (44.0)

28 (60.9)

0.045

 Flaring/Retractionsd

14 (41.2)

5 (38.5)

36 (28.8)

15 (32.6)

0.541

 Retractions, onlyd

2 (5.9)

1 (7.7)

4 (3.2)

4 (8.7)

0.492

 Wheezingd

20 (58.8)

6 (46.2)

62 (49.6)

22 (47.8)

0.750

Admission diagnosis

 Reactive airway disease

3 (8.8)

1 (7.7)

4 (3.2)

1 (2.2)

0.387

 Bronchiolitis

6 (17.7)

3 (23.1)

14 (11.2)

10 (21.7)

0.275

 Bronchopneumonia

14 (41.2)

4 (30.8)

48 (38.4)

13 (28.3)

0.563

 Croup

2 (5.9)

1 (7.7)

0 (0.0)

0 (0.0)

0.010

 Febrile seizure

2 (5.9)

1 (7.7)

4 (3.2)

1 (2.2)

0.697

 Pneumonia

4 (11.8)

0 (0.0)

12 (9.6)

5 (10.9)

0.649

 Pertussis-like cough

0 (0.0)

0 (0.0)

9 (7.2)

4 (8.7)

0.269

 Rule-out sepsis

5 (14.7)

3 (23.1)

40 (32.0)

11 (23.9)

0.211

Classified as LRTI

28 (82.4)

9 (69.2)

84 (67.2)

31 (67.4)

0.382

Chest radiograph

 Abnormal

23/31 (74.2)

8/11 (72.7)

78/116 (67.2)

28/44 (63.4)

0.785

Required supplemental oxygen

11 (32.4)

2 (15.4)

35 (28.0)

14 (30.4)

0.695

Required ICU admission

5 (14.7)

0 (0.0)

9 (7.2)

3 (6.5)

0.318

Required mechanical ventilation

2 (5.9)

0 (0.0)

5 (4.0)

0 (0.0)

0.393

Length of stay (days), median (IQR)

3 (2–6)

5 (3–8)

6 (3–8)

5 (3–8)

0.161

Codetected with ≥1 other virus

21 (61.8)

8 (61.5)

64 (51.2)

30 (65.2)

0.338

Death

0 (0.0)

0 (0.0)

0 (0.0)

1 (2.2)

0.431

  1. a Individual serotypes detected and distinguished by PCR; excludes 3 cases of codetection of PIV-3 and PIV-4
  2. + p < 0.05 considered statistically significant, indicated by bold text
  3. b UMC defined as at least one of the following: diabetes, heart disease, Down syndrome, kidney disease, sickle cell disease, cystic fibrosis, cancer, genetic/metabolic, cerebral palsy, neurological, mental retardation/developmental delay, seizure disorder, chronic diarrhea (eg, > 2 weeks), gastroesophageal reflux disease, immunodeficiency, asthma/reactive airway disease, liver disease
  4. c Reported by parent/legal guardian
  5. d Collected through clinical exam